Microcap Ledger Z Squared Inc. $ZSQR
Facts as of . Built from SEC filings and our own data. Small caps move fast; check the latest filings.
Snapshot
- Exchange
- Nasdaq Global Market
- Sector
- Finance Services
- Headquarters
- Fort Lauderdale, FL
- Fiscal year end
- December 31
- Shares outstanding
- 53,000,397 [10-Q 2026-08-13]
What the company doesAI summary of filing
Z Squared Inc. is a biopharmaceutical and technology company operating through subsidiaries. Its biopharmaceutical division develops cell therapy platforms for cancer, autoimmune, and infectious diseases, including programs such as CD38-GEAR-NK (an autologous gene-edited natural killer cell therapy in pre-clinical stage), CD38-Diagnostic (a discovery-stage in vitro diagnostic tool), SNAP-CAR platform (a preclinical CAR-T cell therapy technology licensed from University of Pittsburgh), and unmodified natural killer cell therapies for acute myeloid leukemia and acute respiratory diseases. Its technology division offers AI-powered marketing software and robotic process automation tools through the NexGenAI platform acquired in December 2024. The company is pre-revenue and relies on research and development partnerships and licensing agreements to advance its product candidates. [10-K 2026-03-19]
Financial health
| Period | Revenue | Net income | Operating cash flow | Cash | Filing |
|---|---|---|---|---|---|
| 6 months to Jun 2026 | $1.58M | −$13.79M | −$202.8K | $15.49M | [10-Q 2026-08-13] |
| FY ended Dec 2025 | $1.36M | −$11.92M | −$8.60M | $1.4K | [10-K 2026-03-19] |
| FY ended Dec 2024 | $0.00 | −$10.68M | −$6.65M | $0.00 | [10-K 2026-03-19] |
- Quarterly cash burn
- −$101.4K
Capital structure and dilution
| Date | Shares outstanding | Filing |
|---|---|---|
| 2025-03-26 | 3,364,939 | [10-K 2025-03-28] |
| 2025-05-14 | 3,513,838 | [10-Q 2025-05-14] |
| 2025-05-26 | 36,089,917 | [10-K/A 2025-06-03] |
| 2025-08-13 | 4,820,317 | [10-Q 2025-08-14] |
| 2025-11-11 | 5,340,111 | [10-Q 2025-11-14] |
| 2026-03-18 | 6,223,221 | [10-K 2026-03-19] |
| 2026-05-12 | 51,431,493 | [10-Q 2026-05-15] |
| 2026-08-11 | 53,000,397 | [10-Q 2026-08-13] |
- Shelf registration
- S-3ASR filed 2026-07-07 [S-3ASR 2026-07-07]
Listing status
Current status: 1 Form 8-K Item 3.01 filing(s) in the last 24 months, most recent 2026-01-16. Item 3.01 covers delisting notices, failures to meet a listing rule and listing transfers; read the filing for which one.
| Date | Event | Details | Deadline | Filing |
|---|---|---|---|---|
| 2026-01-16 | 8-K Item 3.01 | Notice of delisting or failure to satisfy a continued listing rule or standard; or transfer of listing | — | [8-K 2026-01-16] |
Who owns it
| Date | Insider | Type | Shares | Price | Filing |
|---|---|---|---|---|---|
| 2026-09-27 | Sohn Adam Craig | exercise | 274 | — | [4 2026-10-02] |
| 2026-09-27 | Fuerst Bryan Eric | exercise | 274 | — | [4 2026-10-02] |
| 2026-09-27 | Cooper Kenneth Lyle | exercise | 274 | — | [4 2026-10-02] |
| 2026-09-24 | Harris Jeffery Keeslar | exercise | 12,444 | — | [4 2026-10-02] |
| 2026-08-27 | Sohn Adam Craig | exercise | 274 | — | [4 2026-10-02] |
| 2026-08-27 | Fuerst Bryan Eric | exercise | 274 | — | [4 2026-10-02] |
| 2026-08-27 | Cooper Kenneth Lyle | exercise | 274 | — | [4 2026-10-02] |
| 2026-07-27 | Halabu David Elias | exercise | 19,737 | — | [4 2026-10-02] |
| 2026-07-27 | Sohn Adam Craig | exercise | 274 | — | [4 2026-10-02] |
| 2026-07-27 | Fuerst Bryan Eric | exercise | 274 | — | [4 2026-10-02] |
| 2026-07-27 | Cooper Kenneth Lyle | exercise | 274 | — | [4 2026-10-02] |
| 2026-07-27 | Cogley Brian | exercise | 4,112 | — | [4 2026-10-02] |
Catalysts and calendar
| Date | Type | Title |
|---|---|---|
| 2026-09-14 | 8-K | Material agreement entered; Acquisition or disposition completed; Unregistered sale of equity |
| 2026-09-10 | 8-K | Charter, bylaws or fiscal year change |
| 2026-08-26 | 8-K | Director or officer change |
| 2026-08-13 | 10-Q | Quarterly report |
| 2026-08-04 | 8-K | Material agreement entered; Material agreement terminated; Unregistered sale of equity |
| 2026-07-31 | 13G/A | Beneficial ownership report (5%+ holder) |
| 2026-07-22 | 8-K | Material agreement terminated; Regulation FD disclosure |
| 2026-07-10 | 8-K | Material agreement entered |
| 2026-07-07 | 8-K | Material agreement entered |
| 2026-07-07 | S-3ASR | Registration statement |
| 2026-06-30 | 8-K | Director or officer change; Regulation FD disclosure |
| 2026-06-29 | 8-K | Regulation FD disclosure; Other events |
Alerts for $ZSQR
Email me when Z Squared Inc. files an offering, gets a deficiency notice, or moves sharply.
Facts as of . Small caps move fast; check the latest filings.